Position in INDV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$10,216,470
+$7,320,870 QoQ
Shares Held
249,000
+162.1% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#64
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Swedbank AB holds $548,199,348 across 6 Drug Manufacturers - Specialty & Generic names. INDV ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
322,995 | $175,008,380 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
1,201,243 | $133,265,898 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
651,082 | $109,733,360 | |
| 4 | ZTS |
Zoetis Inc.
|
1,485,141 | $106,722,232 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
391,175 | $13,253,008 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
249,000 | $10,216,470 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,216,470 | 249,000 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $2,895,600 | 95,000 | Shares | Defined | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||